Features - Pharmaceutical Technology

Inside the world of priority review vouchers where ‘time is money’ – Part I

Robert Barrie — Thu, 04 Jan 2024 07:00:00 +0000

The first of a two-part series on therapies that receive an FDA priority review designation dives into how these vouchers incentivise innovation for low-commercial value-diseases.

Pursuing an Alzheimer’s breakthrough

Daniel — Thu, 25 Oct 2012 17:30:00 +0000

In short supply: tackling the drug shortage crisis

Nikitha Ladda — Sun, 28 Oct 2012 18:30:00 +0000

Will Obama live up to his promises on AIDS?

Chris Lo — Thu, 08 Nov 2012 18:30:00 +0000

Healthcare’s black hole: preventing pharmaceutical cargo theft

Daniel — Wed, 14 Nov 2012 18:30:00 +0000

People power: crowdfunding clinical research

Chris Lo — Tue, 27 Nov 2012 18:30:00 +0000

November’s top stories: illegal drug testing in India and US eases Iran sanctions

Chris Lo — Wed, 05 Dec 2012 18:30:00 +0000

Saving Syria’s drug supply with Medecins Sans Frontieres

Daniel — Wed, 12 Dec 2012 18:30:00 +0000

The year in review: 2012’s top pharmaceutical stories

Nikitha Ladda — Wed, 19 Dec 2012 18:30:00 +0000

Testing painkillers on humans – why hold back?

Daniel — Thu, 03 Jan 2013 03:30:00 +0000

Nanotechnology: is the elusive cure for cancer in sight?

Daniel — Wed, 13 Jun 2012 17:30:00 +0000

Pharma Technology Focus – Issue 14

Stephanie — Wed, 20 Jun 2012 04:33:00 +0000

Blood drive: new medical devices to pilot through the bloodstream

Liam — Wed, 20 Jun 2012 17:30:00 +0000

Under your skin – redefining drug delivery with implantable microchips

Laura — Mon, 25 Jun 2012 17:30:00 +0000

Superhydrophobic drug release: Q&A with surgical oncologist Yolonda Colson

Nikitha Ladda — Wed, 04 Jul 2012 17:30:00 +0000

Cybercrime in the pharmaceutical industry: a booming business

Daniel — Mon, 09 Jul 2012 17:30:00 +0000

The UK Biobank: what lies ahead?

Daniel — Tue, 17 Jul 2012 17:30:00 +0000

Pharma Technology Focus – Issue 15

Laura — Wed, 18 Jul 2012 05:21:00 +0000

Speeding up European clinical trial regulation

Elisabeth — Sun, 22 Jul 2012 17:30:00 +0000

July’s top stories: the latest trials, lawsuits and drug discoveries

Nikitha Ladda — Tue, 31 Jul 2012 17:30:00 +0000

UK drug maker GlaxoSmithKline pleaded guilty to charges of medical fraud on 2 July and agreed to pay £3bn to settle allegations relating to false advertising and bribes.